Literature DB >> 11515557

Anti-inflammatory and anti-allergic actions by oral administration of a perilla leaf extract in mice.

H Ueda1, M Yamazaki.   

Abstract

The anti-inflammatory and anti-allergic activity of perilla leaf extract was investigated. The oral administration of perilla leaf extract to mice inhibited two types of acute inflammatory models, arachidonic acid-induced ear edema and 12-o-tetradecanoylphorbol-13-acetate-induced ear edema. Oral administration of perilla leaf extract also inhibited the contact dermatitis model, oxazolone-induced ear edema, by affecting sensitization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11515557     DOI: 10.1271/bbb.65.1673

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  10 in total

1.  A methoxyflavanone derivative from the Asian medicinal herb (Perilla frutescens) induces p53-mediated G2/M cell cycle arrest and apoptosis in A549 human lung adenocarcinoma.

Authors:  Amer Ali Abd El-Hafeez; Takashi Fujimura; Rikiya Kamei; Noriko Hirakawa; Kenji Baba; Kazuhisa Ono; Seiji Kawamoto
Journal:  Cytotechnology       Date:  2017-07-14       Impact factor: 2.058

2.  Perilla frutescens Britton var. frutescens leaves attenuate dextran sulfate sodium-induced acute colitis in mice and lipopolysaccharide-stimulated angiogenic processes in human umbilical vein endothelial cells.

Authors:  Yuna Lee; Jungjae Lee; Jihyeung Ju
Journal:  Food Sci Biotechnol       Date:  2019-11-25       Impact factor: 2.391

3.  Perillaldehyde Inhibition of cGAS Reduces dsDNA-Induced Interferon Response.

Authors:  Lei Chu; Chenhui Li; Yongxing Li; Qiuya Yu; Huansha Yu; Chunhui Li; Wei Meng; Juanjuan Zhu; Quanyi Wang; Chen Wang; Shufang Cui
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

4.  Perilla frutescens leaf extract inhibits mite major allergen Der p 2-induced gene expression of pro-allergic and pro-inflammatory cytokines in human bronchial epithelial cell BEAS-2B.

Authors:  Jer-Yuh Liu; Yi-Ching Chen; Chun-Hsiang Lin; Shao-Hsuan Kao
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

5.  Inhibitory activities of Perilla frutescens britton leaf extract against the growth, migration, and adhesion of human cancer cells.

Authors:  Youngeun Kwak; Jihyeung Ju
Journal:  Nutr Res Pract       Date:  2015-01-28       Impact factor: 1.926

6.  Ethanol Extract of Perilla frutescens Suppresses Allergen-Specific Th2 Responses and Alleviates Airway Inflammation and Hyperreactivity in Ovalbumin-Sensitized Murine Model of Asthma.

Authors:  Miaw-Ling Chen; Chi-Heng Wu; Li-Shiuan Hung; Bi-Fong Lin
Journal:  Evid Based Complement Alternat Med       Date:  2015-04-20       Impact factor: 2.629

7.  Evaluation of pentacyclic triterpenes found in Perilla frutescens for inhibition of skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.

Authors:  Jiyoon Cho; Lisa Tremmel; Okkyung Rho; Andrew M Camelio; Dionicio Siegel; Thomas J Slaga; John DiGiovanni
Journal:  Oncotarget       Date:  2015-11-17

8.  Perilla frutescens Extracts Protects against Dextran Sulfate Sodium-Induced Murine Colitis: NF-κB, STAT3, and Nrf2 as Putative Targets.

Authors:  Deung Dae Park; Hye-Won Yum; Xiancai Zhong; Seung Hyeon Kim; Seong Hoon Kim; Do-Hee Kim; Su-Jung Kim; Hye-Kyung Na; Atsuya Sato; Takehito Miura; Young-Joon Surh
Journal:  Front Pharmacol       Date:  2017-08-08       Impact factor: 5.810

9.  Perillaldehyde Ameliorates Aspergillus fumigatus Keratitis by Activating the Nrf2/HO-1 Signaling Pathway and Inhibiting Dectin-1-Mediated Inflammation.

Authors:  Yiqun Fan; Cui Li; Xudong Peng; Nan Jiang; Liting Hu; Lingwen Gu; Guoqiang Zhu; Guiqiu Zhao; Jing Lin
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-06-03       Impact factor: 4.799

10.  Development of User-Friendly Method to Distinguish Subspecies of the Korean Medicinal Herb Perilla frutescens Using Multiplex-PCR.

Authors:  Yonguk Kim; Ah-Young Kim; Ara Jo; Hakjoon Choi; Seung-Sik Cho; Chulyung Choi
Journal:  Molecules       Date:  2017-04-21       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.